30 Years of Evidence
Join the experts’ corner
Featured Content
Health-Related Quality of Life Following Robotic Stereotactic Body Radiation Therapy for High-Risk Prostate Cancer
Retreatment for Resistant or Recurrent Pain in Trigeminal Neuralgia Using Frameless Linac Radiosurgery
Stereotactic Radiosurgery and Radiotherapy for Brainstem Metastases: An International Multicenter Analysis
PO-1128: Radiosurgery with Cyberknife® for arteriovenous malformations: technical and dosimetrical analysis
Esmeralda Scipilliti, Valentina Borzillo, Rossella Di Franco, Federica Savino, Giuseppe Leone, Mario Muto, Paolo Muto | ESTRO | 2022
PD-0085: SBRT in the management of oligometastatic gynaecological cancer: a mono-institutional experience
Giuseppina Mandurino, Andrei Fodor, Stefano Lorenzo Villa, Flavia Zerbetto, Simone Baroni, Ariadna Sanchez Galvan, Roberta Tummineri, Chiara Lucrezia Deantoni, Paola Mangili, Antonella Del Vecchio, Stefano
OC-0932: Preoperative radiation therapy in early breast cancer: phase II ROCK trial (NCT03520894)
Luca Visani, Icro Meattini, Giulio Francolini, Vanessa Di Cataldo, Carlotta Becherini, Jacopo Nori, Marco Bernini, Lorenzo Orzalesi, Luis Sanchez, Erika Scoccimarro, Sara Lucidi, Chiara Bellini,
Adaptive Planning Using PreciseART for Glioblastoma Patient Wearing Tumor Treating Fields Device
Y Qin, R Tobias, R Foster, M Pankuch | AAPM | 2022
An Interpretable Machine Learning Model for Predicting Overall Survival for Malignant Mesothelioma Patients Following Radiotherapy
Z Wang, V Li, X Qi | AAPM | 2022
Impact of Parameter Selection and Setup Conditions On Image Quality of a Novel On-Board Helical KVCT
R Tegtmeier, W Ferris, J Bayouth, W Culberson | AAPM | 2022
Optimal Method of Radixact Treatment Planning for IROC Lung Phantom with Motion Table to Meet VALOR Protocol Constraints
S Klash, E Mcclelland, C Sobotka, S Corbett | AAPM | 2022
Development of Supplemental Pre-Treatment Daily Quality Assurance On the Radixact Real-Time Tumor Tracking System
R Teboh Forbang, B Lewis, A Ndlovu | AAPM | 2022
Evaluation of Surface Dose Prediction Accuracy of Precision Radixact Tomotherapy Treatment Planning System Using OSL Nanodots
A Alphonse, S Pokharel, M Kasper, S Richter, S Rana | AAPM | 2022
A Comparison of AAPM’s TG-51 and IAEA’s TRS-483 Protocols for Clinical Reference Dosimetry of the CyberKnife M6
J Duchaine, D Markel, J-L Ley, D Béliveau-Nadeau, H Bouchard | AAPM | 2022
Dosimetric Evaluation of Stereotactic Prostate Reirradiation Using Cyberknife as An Alternative to HDR Brachytherapy for Locally Recurrent Prostate Cancer
X Zhang, S Jang, S Lee, S Keohan, AE Hirsch | AAPM | 2022
Dosimetric Effect of Intra-Fraction Motion in Multiple Brain Metastases SRS/SRT: An Evaluation Based On a Robotic Radiosurgery System
X Chen, L Chen, J Liu, L Wang, C Ma | AAPM | 2022
Evaluation of the New Independent Dose Calculation SciMoCa as Patient-Specific Quality Assurance in the CyberKnife Treatment of Brain Metastases and Lung Cancer
K Sakai, Y Nakajima, Y Suda, S Kito, Y Sato, K Yasui, Y Arai, T Takizawa, M Sato, Y Fujita | AAPM | 2022
A Dosimetric Comparison for Adaptive Cone-Beam CT and MRI Based Radiotherapy for Stereotactic Partial Breast Irradiation
D Parsons, L Chen, H Lee, Y Zhang, B Cai, T Zhuang, B Hrycushko, C Park, Y Gonzalez, X Zhong, J Visak, C Nwachukwu, N
Dosimetric Evaluation of the Treatment Goals Effectiveness of VMAT / Cyber Knife Versus IMPT When LET / Variable RBE Are Taken Into Consideration for Brain Tumors
H Kamal Sayed, Q Xu, J Fan | AAPM | 2022
Moderate Hypofractionation with Simultaneous Integrated Boost in Prostate Cancer: Long-term Results of a Phase I-II Study
Di Muzio NG, Fodor A, Noris Chiorda B, Broggi S, Mangili P, Valdagni R, Dell’Oca I, Pasetti M, Deantoni CL, Chiara A, Berardi G, Briganti A, Calandrino R, Cozzarini C, Fiorino C | Clin Oncol | 2016
High-Dose-Rate Brachytherapy Monotherapy versus Image-Guided Intensity-Modulated Radiotherapy with Helical Tomotherapy for Patients with Localized Prostate Cancer
Yamazaki H, Masui K, Suzuki G, Nakamura S, Shimizu D, Nishikawa T, Okabe H, Yoshida K, Kotsuma T, Tanaka E, Otani K, Yoshioka Y, Ogawa K | Cancers (Basel) | 2018
Intensity-Modulated Radiation Therapy with Simultaneous Integrated Boost for Clinically Node-Positive Prostate Cancer: A Single-Institutional Retrospective Study
Onishi M, Kawamura H, Murata K, Inoue T, Murata H, Takakusagi Y, Okonogi N, Ohkubo Y, Okamoto M, Kaminuma T, Sekihara T, Nakano T, Ohno T | Cancers (Basel) | 2021
Post-operative hypofractionated radiotherapy for prostate cancer: a mono-institutional analysis of toxicity and clinical outcomes
Ferrera G, D’Alessandro S, Cuccia F, Serretta V, Trapani G, Savoca G, Mortellaro G, Lo Casto A | J Cancer Res Clin Oncol | 2022
Moderate Hypofractionated Helical TomoTherapy for Older Patients with Localized Prostate Cancer: Long-term Outcomes of a Phase I-II Trial
Cui D, Du L, Yu W, Cai B, Meng L, Yang J, Luo Y, Chen J, and Ma L | Radiol Oncol| 2022
Adaptive Radiotherapy for Carcinoma of the Urinary Bladder: Long-term Outcomes With Dose Escalation
Murthy V, Gupta P, Baruah K, Krishnatry R, Joshi A, Prabhash K, Noronha V, Menon S, Pal M, Prakash G, Bakshi G | Clin Oncol | 2019
Use of Nab-Paclitaxel Plus Gemcitabine Followed by Hypofractionated Tomotherapy With Simultaneous Integrated Boost in Patients With Locally Advanced Pancreatic Cancer – PubMed (nih.gov)
Shi Z, Yang J, Kong W, Qiu X, Lu C, Liu J, Liu B, and Du J | Front Oncol | 2022
Improved oncologic outcomes with image-guided intensity-modulated radiation therapy using helical tomotherapy in locally advanced hepatocellular carcinoma
Yoon HI, Lee IJ, Han KH, Seong J | J Cancer Res Clin Oncol | 2014